In this study, we performed an in-depth and all-inclusive bioinformatics analysis of KIF18A expression in gliomas according to some clinical datasets, and its role as a potential therapeutic target and independent prognostic factor was evaluated. Here, KIF18A is linked to central nervous system cancer.